Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.11.22 (
cdc2
)
8,319
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
We have identified mutations in the Drosophila
cdc2
gene. The recessive lethality of these mutant alleles was rescued after P-element-mediated transformation with a genomic
cdc2
fragment. Sequence analysis of amorphic alleles revealed non-conservative exchanges in evolutionary conserved positions. These alleles caused lethality at the larval-pupal interphase due to the absence of imaginal tissues. Embryonic lethality resulted when the maternal Dm
cdc2
contribution was reduced through the use of a temperature-sensitive allele. Dm
cdc2
function, therefore, is essential for cell proliferation throughout development. Dm
cdc2
function is clearly required for mitosis, but no evidence for a requirement in S-phase was obtained. The reversible block of the mitotic proliferation which was observed in the
PNS
of mutant embryos occurred exclusively in the G2-phase. Moreover, while the mitotic proliferation of imaginal cells was blocked in the amorphic mutant larvae, non-imaginal larval cells continued to grow and endoreplicate their DNA. The Dm
cdc2
mutant phenotype could neither be rescued with Dm cdc2c (encoding a
cdc2
-like kinase) nor enhanced by a reduction of the Dm cdc2c gene dose. These results indicate that the Dm
cdc2
- and Dm cdc2c-kinases control different processes.
...
PMID:Genetic analysis of the Drosophila cdc2 homolog. 822 48